Olema Pharmaceuticals, Inc. (OLMA) Form 8-K — Oct 15, 2026
Olema Pharmaceuticals disclosed that Dr. Gorjan Hrustanovic resigned from its Board of Directors effective October 14, 2026, also stepping down from the Compensation and Science & Technology Committees. The company stated the resignation was not due to any disagreement over operations, policies, or practices. On October 15, 2026, the Board appointed existing director Dr.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.